...Emerging Economies and Globalization Argosy University Module 5: Assignment 1 LASA 2 BUS6512 Jerome Bates June 4, 2015 Table of Contents Abstract……..………………………………………………………………………………p.3 General Electric Health (History)..…………………………………………………………p.4 Theories Behind the GE Healthcare Move…………………………………………………p.4 International Product Lifecycle.…………………………………………………………....p.5 Comparative Advantage……………………………………………………………………p.6 Possible Pitfall of the Strategy……………………………………………………………..p.8 Solutions to Pitfalls…………………………………………………………………………p.9 HR Strategy in India………………………………………………………………………..p.9 HR Strategy in China……………………………………………………………………….p.10 Training Design (India,China)………………………………………………………………p.10 Conclusion…………………………………………………………………………………..p.11 References………………………………………………………………..…………………p.12 Abstract Untapped markets are not always available, but are out there; the question is, how do you find those markets? How do you tap the untapped? How do you find untapped markets with the proliferation of growth in economies, societies and markets within a world that is becoming a market without defined borders? As companies continue to grow and trade also expands, it now is crucial that MNC’s looking to expand their business, look for growth in a global lens sense. In this essay, the discussion will be just that. How MNC’s can reach untapped markets and expand the growth of their business, most notably, General Electric Health. This has been made possible due to the continuous...
Words: 2926 - Pages: 12
...experts Emerging Consumer Survey 2015 EMERGING CONSUMER SURVEY 2015_2 Contents 03 Editorial 04 The emerging consumer in 2015 12 A sum of different parts 20 e-Commerce and the emerging consumer 30 Focus on travel 36 Focus on autos 40 Focus on healthcare 46 Brands and the emerging consumer in 2015 62 Brazil: Steady decline continues 64 China: A life online 66 India: New government, strong consumer 68 Indonesia: An under-penetrated market 70 Mexico: Structural potential, cyclical hurdles 72 Russia: Dark clouds gather 74 Saudi Arabia: The petro-dollar 76 South Africa: Reduced optimism 81 About the survey 83 Imprint / Disclaimer For more information, please contact: Richard Kersley, Head of Global Securities Products and Themes, Credit Suisse Investment Banking, richard.kersley@credit-suisse.com Michael O’Sullivan, Chief Investment Officer UK & EMEA, Credit Suisse Private Banking & Wealth Management, michael.o’sullivan@credit-suisse.com COVERPHOTO: ISTOCKPHOTO.COM/XAVIERARNAU, PHOTO: ISTOCKPHOTO.COM/ALIJA 78 Turkey: Subdued but stable EMERGING CONSUMER SURVEY 2015_3 Editorial We are delighted to publish the fifth edition of the Credit Suisse Research Institute’s “Emerging Consumer Survey.” To undertake the project, we have again partnered with global market research firm Nielsen, which has conducted on our behalf nearly 16,000 face-to-face interviews with consumers across nine key emerging economies –...
Words: 21734 - Pages: 87
...IIM BANGALORE Final Report for Contemporary Concerns Study Project Repositioning Strategy for Indian Pharmaceutical Companies in Global Context Submitted to PROFESSOR MURALI PATIBANDLA (FACULTY,CORPORATE STRATEGY AND POLICY) Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ..............................................................................................................
Words: 7934 - Pages: 32
...private institutions, well-developed infrastructure, stable macroeconomic environment and healthy workforce that has received at least a basic education. First of all, India’s growth rate is currently struggling. Many populations in India still live in extreme poverty, such a low standard of living will result in low purchasing power, which is a negative element that prohibits economic development. High inflation, deficient institutions and closeness in India are all the issues for the deterioration in India's competitiveness. Secondly, immature infrastructure, especially transportation and electricity, hinders for the economic development in India. Thirdly, India has the lowest increasing rate of PPP in recent years among BRICs. India’s fiscal situation remains in trouble, and with the exception of 2007, India government has consistently run deficits since 2000. Moreover, the decline in business sophistication, financial market development, and goods market efficiency, stifling business regulation, weak foreign investment and a widening trade deficit lead to a weak business environment in India. Fourthly, low income workforce suffers from issues in education and healthcare, because low productivity of agruculture in India represents 18% output but nearly half employees. People still lack higher education and training, consequently, short of talents with high skills restricts the development and innovation of the country. 2. How does this deterioration affect the...
Words: 721 - Pages: 3
...Indian Institute of foreign trade | Critical Analysis | Identifying International Marketing Opportunities in Medical Services | 04-Nov-12 | Background Medical tourism is becoming a popular option for tourists across the globe. It includes primarily and predominantly healthcare facilities, combined with travel and tourism. The term medical tourism describes the rapidly growing practice of travelling across international borders to obtain cost-effective and high quality medical care. Various countries like Thailand, Malaysia, India, etc are promoting medical tourism aggressively. The key competitive advantages of India in medical tourism stem from the following: low cost advantage, strong reputation in the advanced healthcare segment (cardiovascular surgery, organ transplants, eye surgery etc.) and the diversity of tourist destinations available in the country. The key concerns facing the industry include: absence of government initiative, lack of a coordinated effort to promote the industry, no accreditation mechanism for hospitals and the lack of uniform pricing policies and standards across hospitals. Medical tourism or health care tourism is a rapidly growing multibillion-dollar industry around the world. It is an economic activity that comprises trade in medical services and represents the mixing of two of the largest world industries: medicine and tourism. The case identifies the strengths of India’s medical tourism service providers and points at a number of problems...
Words: 2665 - Pages: 11
...Healthcare delivery in India - effects of Public policy, IT and Insurance Bhavik Kaul 1 Gaurav Dalvi 2 Great Lakes Institute of Management, Chennai October 2012 Abstract The global healthcare industry has greatly transformed itself into a professional service system, wherein each stakeholder has to justify its performance. In the increasingly globalized market, private healthcare providers have started dominating the supply side. Healthcare sector in India needs to be reoriented globally towards excellent service promotions and healthcare be made available at lower cost. With this view we plan to study the impact of various factors on the quality of healthcare delivery in India over the next decade. This research will attempt to verify the impact of the mentioned crucial factors on the Healthcare delivery in India through an empirical research and provide some assessment of the deficit in access to health services through structured integrated way called the Gaps Model of Service Quality which will take into account significant gaps identified & suggest methods to close the gaps. These suggestions will be used to make recommendations towards a 10 year incremental National Health Plan. 1. Theory & Hypothesis The 3 areas that we intend to include into our study of the healthcare landscape are – 1) Public Policy 2) Insurance 3) Healthcare Information Technology Systems (HIT) a. Hypothesis 1: Favorable National Health policies will have a positive impact...
Words: 2192 - Pages: 9
...0911138 Global Pharmaceutical Market - Overview The increasing generics share and shift of the industry towards emerging markets is causing margin pressure on global pharma players and forcing them to invest in these new markets Global Pharmaceutical Market The pharmaceutical market was $ 820Bn in Other Patented 86% 83% 81% 79% 2009, growing at a CAGR of 9% over 200309 Generics is growing at double the rate of the Generics 2004 2006 2008 2010E total industry (18% CAGR), while Patented drugs market is growing at 7% India 1% Geographical Market Share Middle Africa 1% East 1% CIS 2% Others 12% US 42% Top 10 countries account for 73% of sales US accounts for 42% of the world sales While the US sales are growing at only 1-2% CAGR, growth in emerging markets is over 10% Latin America 6% South East and East Asia 6% EU 29% Source: Centrum Research Report on Pharma Industry 2009; 2 Key Growth Drivers for Global Pharmaceutical Market 1 Sluggish Growth in Mature Markets Economic slowdown leading to reduced healthcare spending Top brands’ patent expiries and very few new product launches Decentralization of government healthcare budgets. High healthcare expenditure by government 2 Faster Growth in Emerging Markets Broader public and private healthcare funding Greater access to, and demand for, innovative medicines 250 200 150 100 50 0 3 Pressure on healthcare budgets worldwide More doctors...
Words: 3256 - Pages: 14
...4440 APRIL 27, 2012 DOROTHY LEONARD SUNRU YONG Bella Healthcare India Joseph Cherian, country director of Bella Healthcare in India, wondered whether his team was ready for Project TKO. He listened intently as Jeremy Manning, his director of research and development, described the pros and cons of the project, a proposal to develop a new portable electrocardiograph machine (EKG) specifically for the Indian market. Cherian believed the time was right to tackle the tough, but fast-growing Indian market. The key question was whether Bella India’s local R&D team, under Manning’s direction, was ready to lead the product development: My goal has always been to develop products that serve emerging markets and make healthcare more accessible. I think medical device companies are learning that this can be done most effectively by those who know these markets best. We should develop our affordable EKG in India, for India. Bella India has proven itself in manufacturing and cost- engineering; this is the next logical step. The endeavor was not without risk. The costly failure of Project Baton, a global product development effort, was fresh on everyone’s mind. Failure with Project TKO would not only hurt Bella Healthcare’s overall profitability, it would undermine Cherian’s case that the India operation was ready for more challenging product development undertakings. Industry Background: Electrocardiogram Equipment Electrocardiography, commonly referred...
Words: 5833 - Pages: 24
...Emerging Trends in Healthcare A Journey from Bench to Bedside 17 February 2011 © 2011 KPMG, an Indian Partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. Acknowledgement India’s competitive advantage lies in the lower production and research cost, its large pool of low cost technical and scientifically trained personnel, and large number of compliance certified manufacturers and service providers, which make us different from others. ASSOCHAM feels that technology incubation is no longer confined to a few institutions; it is a responsibility that we have to share, if we wish to see a better and a healthy future ahead. There is an immense need to develop skilled manpower in the area of healthcare and modern as well as traditional medicines. I am glad that this Summit on Emerging trends in Healthcare will bring forth the journey from research desk to the bedside of patient, as we will look at healthcare at the frontline to identify some common challenges that may help explain the complex nature of healthcare and the scale of the “change” challenge. I wish to thank KPMG for unanimously contributing towards this Knowledge Paper, which gives a rich and comprehensive insight of the trend in healthcare. I would also take the opportunity to thank QCI for supporting this event. The case studies contributed providing the best of...
Words: 17817 - Pages: 72
... Strong growth opportunities • The IT-BPM sector in India is estimated to expand at a CAGR of 9.5 per cent to USD300 billion by 2020. The sector increased at a CAGR of 25 per cent over 2000–13, 3-4 times higher than global IT-BPM spend • Leading sourcing destination India is the world’s largest sourcing destination, accounting for approximately 52 per cent of the USD124–130 billion market. The country’s cost competitiveness in providing IT services, which is approximately 3-4 times cheaper than the US continues to be its USP in the global sourcing market Largest pool of ready to hire talent • India’s highly qualified talent pool of technical graduates is one of the largest in the world, facilitating its emergence as a preferred destination for outsourcing Most lucrative sector for investments • The sector ranks fourth in India’s total FDI share and accounts for approximately 37 per cent of total Private Equity and Venture investments in the country Source: NASSCOM; Aranca Research Note: BPM - Business Process Management, USP - Unique Selling Proposition 2013E • Growing demand Growing demand Strong growth in demand for exports from new verticals Expanding economy to propel growth in local demand • • Global footprints IT firms in India have delivery centres across the world; as of 2012, IT firms had a total of 580 centres in 75 countries India’s IT & ITes industry is well diversified across verticals such as...
Words: 3882 - Pages: 16
...Pharmaceutical and Medical Products Practice India Pharma 2020 Propelling access and acceptance, realising true potential The report is furnished to the recipient for information purposes only. Each recipient should conduct its own investigation and analysis of any such information contained in this report. No recipient is entitled to rely on the work of McKinsey & Company, Inc. contained in this report for any purpose. McKinsey & Company, Inc. makes no representations or warranties regarding the accuracy or completeness of such information and expressly disclaims any and all liabilities based on such information or on omissions therefrom. The recipient must not reproduce, disclose or distribute the information contained herein without the express prior written consent of McKinsey & Company, Inc. 12 Executive summary India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. The Indian pharmaceuticals market, along with the markets of China, Brazil and Russia, will spearhead growth within these markets. The Indian pharmaceuticals market has characteristics that make it unique. First, branded generics dominate, making up for 70 to 80 per cent of the retail market. Second, local players have enjoyed a dominant position driven by formulation...
Words: 9542 - Pages: 39
...bella case As Bella India was enjoying its first product development success, it also continued to demonstrate and improve its reengineering and cost-cutting capabilities. These competencies had enabled the Bangalore facility to capture significant savings with the 6-channel and 12-channel EKGs, Holter monitors, and defibrillators. Seeing these savings boost the bottom line, Bella’s senior team actively encouraged greater collaboration between headquarters and Bella India. The time between a product introduction in St. Louis and the transition to exclusive manufacturing in Bangalore continued to shrink. Increasingly, cost reduction opportunities were identified jointly by the Bangalore and St. Louis teams and incorporated into the initial product design. With this capability well-developed and the successful launch of the Fiit X17, Cherian and St. Louis management agreed to tackle a new challenge in 2005: the joint development by St. Louis and Bella India of an entirely new product. Bella Healthcare initiated Project Baton to design a new, lower-cost stress test system to be used with treadmills. Stress test systems were expensive relative to resting and portable EKGs, but they had tremendous value in clinical diagnosis, and global demand for this product was strong. With Project Baton, the company would challenge this market segment by developing a more affordable offering. Bella Healthcare was not the only player attempting to do this, and it was clear from the outset that...
Words: 1840 - Pages: 8
...Dr. Reddy’s Laboratories Ltd At Dr. Reddy’s strives every day to do what matters most to patients: accelerating access to affordable medicines and finding solutions for unmet needs. Company’s Generics products bring expensive medicines within reach of patients by helping reduce the cost of therapy. Company’s portfolio consists of all dose forms in multiple therapeutic areas as well as biologic drugs. Company also serves patients through it’s partners. For one, company supply other generics companies with active pharmaceutical ingredients, which helps them quickly bring medicines to market and create affordable options to high cost medicines. Company also helps innovator companies get their proprietary medicines to patients faster by providing a range of products and services. To address unmet patient needs, company develops innovative products that increase patient convenience and/or enhance a drug’s safety or efficacy. These include novel formulations of currently marketed drugs or combinations of complementary drugs that address significant unmet needs. Company also have an active drug discovery program to discover and develop new chemical entities in key therapeutic areas. To help manage disease better company go beyond providing medicines. In ailments such as cancer, hypertension, diabetes and kidney disease, company provide services that help stay on course with prescribed treatments through daily reminders about medication and follow-up as needed, facilitate counselling...
Words: 1937 - Pages: 8
...July-December, 2013 Business Perspectives and Research Reverse Innovation: A Gift from Developing Economy to Developed Economy Ritu Sinha 1 Abstract In the era of globalization, emerging market economies are surfacing into centers of innovation. These innovations associate with low-cost products like healthcare devices, wind power, micro finance, electric cars and many more. The success of these frugal innovated products enable developed countries to adopt well. Hence, reverse innovation refers to those innovations which are adopted by developing countries first and then by developed countries. These innovative products are a result of cutting edge technology, common sense and ingenious use of local commodities with the price range that is affordable to a huge mass of consumers like Tata's one lakh ($ 1677) car Nano, Nokia's sturdy mobile phones, the Chottu Cool' refrigerator and many more. These products might be conceptualized for the customers at the bottom of the pyramid still not limited by scaled down versions meant for the lower end. This paper is an attempt to evaluate how reverse innovations are possible in emerging markets and how it can unlock business opportunities at a global scale. Keywords Emerging market, frugal, innovation, product reverse, technology 1. Introduction In today's changing and competitive environment, innovation is must for the survival of any kind of business in the marketplace. The primary objective of any business firm is to understand...
Words: 5774 - Pages: 24
...Airtel, Vodafone, Idea Cellular Ltd, Reliance Telecom Ltd, etc. are following to safeguard their profitability. The report discusses about the two fold strategy of tapping the rural market within India and netting talkers in emerging economies, followed by mobile operators in India to de-risk them. Whether it is the rural Indian market or other emerging markets, operators would be busy acquiring subscribers. This, in turn, may result in erosion in profitability. There is no question of profitability. It is all about registering your presence and building psychological pressure. On the other hand, the Indian market has yet to take-off when it comes to offering data-intensive mobile value-added services like m-commerce, healthcare services, governance, education, information and location-based services. But these areas are already contributing to revenues in many African and Middle Eastern countries. In rural India, the cell phone is not replacing anything of importance. In all probability, operators would experiment with voice services for 18-24 months before offering such value-added services. Further, extensive networks alone would not ensure better business. Branding, marketing and making relevant services available are more important. Whether Indian telecom companies' rural and emerging...
Words: 298 - Pages: 2
